These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22449348)

  • 1. Morphologic markers of progressive immunoglobulin A nephropathy.
    Haas M; Reich HN
    Adv Chronic Kidney Dis; 2012 Mar; 19(2):107-13. PubMed ID: 22449348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
    Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
    Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
    Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discriminant analysis of clinical markers before renal biopsy in patients with IgA nephropathy].
    Yagame M
    Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):735-42. PubMed ID: 2585827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 expression in IgA nephropathy.
    Florquin S; Nunziata R; Claessen N; van den Berg FM; Pals ST; Weening JJ
    Am J Kidney Dis; 2002 Feb; 39(2):407-14. PubMed ID: 11840384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise semiquantitative histological scoring system for immunoglobulin A nephropathy.
    Jiang L; Liu G; Lv J; Huang C; Chen B; Wang S; Zou W; Zhang H; Wang H
    Nephrology (Carlton); 2009 Sep; 14(6):597-605. PubMed ID: 19422527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking and progression of IgA nephropathy.
    Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
    Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxford classification of immunoglobulin A nephropathy: an update.
    Roberts IS
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):281-6. PubMed ID: 23518465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of urinary interleukin 6 in IgA nephropathy.
    Dohi K; Iwano M; Muraguchi A; Horii Y; Hirayama T; Ogawa S; Shiiki H; Hirano T; Kishimoto T; Ishikawa H
    Clin Nephrol; 1991 Jan; 35(1):1-5. PubMed ID: 2007290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy: an update on pathogenesis and classification.
    Mubarak M
    J Coll Physicians Surg Pak; 2011 Apr; 21(4):230-3. PubMed ID: 21453621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic correlation in IgA nephropathy.
    Philibert D; Cattran D; Cook T
    Semin Nephrol; 2008 Jan; 28(1):10-7. PubMed ID: 18222342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
    Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
    Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary nephropathy due to mesangial deposits of IgA (Berger's disease)].
    Rosenberg H
    Rev Med Chil; 1990 Feb; 118(2):125-33. PubMed ID: 2152710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy in teaching hospitals of Dhaka.
    Sharmin F; Khan BR; Rahman M; Rashid HU; Islam B; Kamal M; Barua AR; Chowdhury MA; Mohsin AU; Ahmed S
    Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):25-9. PubMed ID: 9363674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotic crescentic glomerulonephritis and IGA nephropathy: Lee-Haas classification revisited.
    Jabur WL
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):784-7. PubMed ID: 21743230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting progression in IgA nephropathy.
    Bartosik LP; Lajoie G; Sugar L; Cattran DC
    Am J Kidney Dis; 2001 Oct; 38(4):728-35. PubMed ID: 11576875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.